FIG. 2.
Mean oritavancin plasma and blister fluid concentrations versus time during the 24 h following the third 200-mg dose. Circles, oritavancin in plasma; squares, oritavancin in blister fluid. Each sample represents the mean ± SD; n = 8.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.